Home Antitrust Chronicle 2012 Summer 2012, Volume 7, Number 2

Summer 2012, Volume 7, Number 2

chronicle

Looking for Sense in the Italian Antitrust Authority Decision in the...

Daniela Ampollini, Jul 27, 2012 The January 2012 decision of the Italian Antitrust Authority ("IAA") in the Pfizer case, involving Pfizer's actions to counter the marketing...

European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The...

Sean-Paul Brankin, Jul 27, 2012 On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal...

Pharmaceutical Patents, Settlements, Reverse Payments, and Exclusion: Update

John Bigelow, Jul 27, 2012 In the June issue of this Chronicle my fellow contributors and I described a trend in appellate court decisions involving...

Why a Reduction in Health Care Costs Per Se May be...

Rosa Abrantes-Metz, Jul 27, 2012 There is nearly universal agreement that a restructuring of the health care system is required, particularly with regard to the...

The Extraterritorial Effect of Antimonopoly Law

Kai Zhang, Jul 27, 2012 Monopoly refers to the phenomenon whereby a specific person or enterprise accrues substantial profits by controlling the production and selling...

News

Antitrust Mix by CPI